Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Objectives: We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results.Subjects and Methods: We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated.Results: Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B): 10.309, 95% confidence interval (CI): 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B): 1.042, 95% CI: 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B): 25.641, 95% CI: 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results.Conclusions: A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.
Abstract
Background and Objectives: We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results.Subjects and Methods: We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated.Results: Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B): 10.309, 95% confidence interval (CI): 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B): 1.042, 95% CI: 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B): 25.641, 95% CI: 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results.Conclusions: A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.
참고문헌 (28)
- Morita S, "A comparison of the short-term outcome in patients with acute low-tone sensorineural hearing loss", ORL J Otorhinolaryngol Relat Spec, 72, pp.295~299 (2010)
- Yoshida T, "Idiopathic sudden sensorineural hearing loss and acute low-tone sensorineural hearing loss : a comparison of the results of a nationwide epidemiological survey in Japan", Acta Otolaryngol, 137, pp.S38~S43 (2017)
- 장진경, "Short-Term Outcomes of Acute Low-Tone Sensorineural Hearing Loss According to Treatment Modality", Journal of Audiology & Otology, 20(1), pp.47~52 (2016), 대한청각학회
- Junicho M, "Prognosis of low-tone sudden deafness-does it inevitably progress to Meniere’s disease", Acta Otolaryngol, 128, pp.304~308 (2008)
- Yamasoba T, "Acute low-tone sensorineural hearing loss without vertigo", Arch Otolaryngol Head Neck Surg, 120, pp.532~535 (1994)
- 노경진, "Long-Term Outcomes of Acute Low-Tone Hearing Loss", Journal of Audiology & Otology, 19(2), pp.74~78 (2015), 대한청각학회
- Basura GJ, "Clinical practice guideline : Ménière’s disease executive summary", Otolaryngol Head Neck Surg, 162, pp.415~434 (2020)
- Crowson MG, "A systematic review of diuretics in the medical management of Ménière’s disease", Otolaryngol Head Neck Surg, 154, pp.824~834 (2016)
- Stölzel K, "Comorbid symptoms occurring during acute low-tone hearing loss(AHLH)as potential predictors of Menière’s disease", Front Neurol, 9, pp.884~ (2018)
- Palmer BF, "Metabolic complications associated with use of thiazide diuretics", J Am Soc Hypertens, 1, pp.381~392 (2007)
- Lee JD, "Is dehydration test using isosorbide useful in Meniere’s disease", Acta Otolaryngol, 136, pp.1107~1109 (2016)
- Zhu Y, "Meta-analysis comparing steroids and diuretics in the treatment of acute low-tone sensorineural hearing loss", Ear Nose Throat J, 100, pp.281S~285S (2021)
- Fuse T, "Shortterm outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid", ORL J Otorhinolaryngol Relat Spec, 64, pp.6~10 (2002)
- Suzuki M, "Effect of corticosteroids or diuretics in low-tone sensorineural hearing loss", ORL J Otorhinolaryngol Relat Spec, 68, pp.170~176 (2006)
- Choo OS, "Differences in clinical characteristics and prognosis of sudden low-and high-frequency hearing loss", Laryngoscope, 127, pp.1878~1884 (2017)
- Fushiki H, "Prognosis of sudden low-tone loss other than acute low-tone sensorineural hearing loss", Acta Otolaryngol, 130, pp.559~564 (2010)
- Alatas N, "Use of intratympanic dexamethasone for the therapy of low frequency hearing loss", Eur Arch Otorhinolaryngol, 266, pp.1205~1212 (2009)
- Lee CK, "Significance of 1 kHz pure-tone threshold in acute low-frequency sensorineural hearing loss", Otol Neurotol, 39, pp.e950~e955 (2018)
- Morita S, "The short-and long-term outcome of intratympanic steroid therapy as a salvage treatment for acute low-tone sensorineural hearing loss without episodes of vertigo", Audiol Neurootol, 21, pp.132~140 (2016)
- Sato H, "Epidemiological survey of acute low-tone sensorineural hearing loss", Acta Otolaryngol, 137, pp.S34~S37 (2017)
- Jung AR, "Clinical characteristics and prognosis of low frequency sensorineural hearing loss without vertigo", Acta Otolaryngol, 136, pp.159~163 (2016)
- 박명진, "Clinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo", Clinical and Experimental Otorhinolaryngology, 11(2), pp.96~101 (2018), 대한이비인후과학회[DOI]
- Shimono M, "Endolymphatic hydrops revealed by magnetic resonance imaging in patients with acute low-tone sensorineural hearing loss", Otol Neurotol, 34, pp.1241~1246 (2013)
- Inui H, "Magnetic resonance imaging of the endolymphatic space in patients with acute low-tone sensorineural hearing loss", Auris Nasus Larynx, 46, pp.859~865 (2019)
- Wu CL, "Vestibular evoked myogenic potentials in acute low-tone sensorineural hearing loss", Laryngoscope, 114, pp.2172~2175 (2004)
- Wang CT, "Vestibular-evoked myogenic potential in the prediction of recovery from acute low-tone sensorineural hearing loss", Ear Hear, 31, pp.289~295 (2010)
- Im GJ, "Analysis of audio-vestibular assessment in acute low-tone hearing loss", Acta Otolaryngol, 136, pp.649~654 (2016)
- 김현정, "Update on Clinical Manifestation in Acute Low-Tone Hearing Loss", 대한이비인후-두경부외과학회지, 63(9), pp.403~408 (2020), 대한이비인후과학회[DOI]